Advertisement
Delay in Cancer Treatment Linked to Increased Mortality

Women Forgoing Reconstruction After Mastectomy Pleased

0

22 percent experienced 'flat denial,' when the option of no reconstruction after mastectomy was not initially offered

HealthDay Reports: COVID-19 Exacts Emotional Toll on Doctors

Mental Health Disorders Common Among ICU Staff During COVID-19

0

45 percent of respondents met threshold for probable clinical significance on measures of depression, PTSD, anxiety, problem drinking

Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses Up

0

Estimated rates of NAS, maternal opioid-related diagnoses increased from 2010 to 2017 in the U.S., with variation between states

Cognitive Performance During Menopause Transition Examined

0

Longitudinal declines seen in measures of learning, memory, attention/working memory domains in low-income women of color

Counseling on Gun Safety Could Cut Suicide Rate in Military: Study

Lethal Means Counseling, Cable Locks Promote Safe Firearm Storage

0

Lethal means counseling outperformed control at six months; cable locks outperformed control at three, six months

Practice’s Bariatric Nonsurgical Visits Up With Telehealth During Pandemic

0

Follow-up visits increased for nonsurgical providers; however, new patient and follow-up surgical visits did decrease

12/2 -- Years Before Diagnosis

Financial Toxicity Linked to QOL After Breast Cancer Surgery

0

Strongest correlation seen for BREAST-Q psychosocial well-being, with 0.89 change per unit change in financial toxicity score

Maternal Use of Valproic Acid Linked to ASD

Few Ob-Gyns Can Prescribe Buprenorphine for Opioid Use

0

Obstetrician-gynecologists able to prescribe buprenorphine more likely located in the suburbs

WHO: Remdesivir Not Advised for Hospitalized COVID-19 Patients

Experimental Drug for Alzheimer Disease Shows Promise

0

After six to 12 months of treatment with the drug, patients no longer had amyloid protein plaques

Autism May Raise Risk for Substance Use Disorder

0

Risk for SUD lower for subgroups of individuals with ASD receiving one or multiple psychotropic agents